Trial · NCT07878286
The Role of Interoceptive Sensitivity in Central Sensitization Symptom Severity in Fibromyalgia
NCT07878286, Recruiting, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Role of Interoceptive Sensitivity in Central Sensitization Symptom Severity in Fibromyalgia. Trials, record NCT07878286. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07878286
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Role of Interoceptive Sensitivity in Central Sensitization Symptom Severity in Fibromyalgia
- NCT number
- NCT07878286
- Status
- Recruiting
- Enrollment
- 110 participants, estimated
- Lead sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Conditions
- Fibromyalgia, Interoception, Central Sensitization
- Interventions
Central Sensitization Inventory, The Multidimensional Assessment of Interoceptive Awareness scale-2, Revised Fibromyalgia Impact Questionnaire, Numeric rating scale, Hospital Anxiety and Depression Scale
- First posted
- 2026-10-16
- Last updated
- 2026-10-16
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Multidimensional Assessment of Interoceptive Awareness-2, MAIA-2 | baseline | The participant is required to evaluate "how often each statement generally applies to you in daily life" using a six-point Likert scale with 32 items, where responses range from 0 ("never") to 5 ("always"). The score for each scale is calculated by averaging the scores of its items (ranging from 0 to 5), with higher scores indicating a higher expression of the internal perception components examined by the survey. |
| Secondary | Central Sensitization Inventory, CSI | Baseline | The central sensitization scale is a tool used to assess the hypersensitivity of the central nervous system. This scale includes questions that examine individuals' pain perception and its effects on daily life to detect the effects of central sensitization, which are often seen in chronic pain conditions. The scale evaluates how individuals perceive pain in response to physical contact or other stimuli (pain sensitivity), changes in their sensitivity to hot, cold, or pressure (sensory changes), how the persistence of pain affects their daily activities, and the impact of pain on their emotional state (anxiety, depression, etc.). |
| Secondary | Revised Fibromyalgia Impact Questionnaire | Baseline | It will be used to evaluate the disease impact and symptom severity related to fibromyalgia in participants. It is a scale that evaluates the functional status, overall disease impact, and symptom severity in fibromyalgia patients over the past 7 days. As the total score obtained increases, it is accepted that the disease impact associated with fibromyalgia also increases. |
| Secondary | HOSPITAL ANXIETY AND DEPRESSION SCALE | Baseline | It is a 14-item self-report scale that quickly, reliably, and independently of medical conditions assesses patients' anxiety and depression symptoms over the past week. |
| Secondary | Numeric Pain Rating Scale, NPRS | Baseline | Pain severity will be evaluated using a scale ranging from 0 (no pain) to 10 (unbearable pain). Participants will be asked to rate their average pain levels over the past week. |
| Secondary | Fatigue Severity Scale | Baseline | It will be used to assess the participants' level of fatigue. The scale is a 9-item measure that evaluates the impact of fatigue on daily life activities, physical function, motivation, and social life. The items are scored on a scale of 1-7, with higher scores indicating greater fatigue severity. |
| Secondary | Pittsburgh Sleep Quality Index | Baseline | It will be used to evaluate the sleep quality of the participants. It is a scale that evaluates sleep quality and sleep disorders within the last month. The scale consists of seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The total score ranges from 0 to 21, with higher scores indicating worse sleep quality. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07878286
GET https://conductscience.org/api/trials/v1/NCT07878286/registered